Published in Medical Imaging Business Week, April 21st, 2005
"This overview presents the indications of tumor SPECT in contrast to tumor PET using F-18-FDG. A number of diagnostic SPECT radiopharmaceuticals have been used for years in oncology and ore widely available in nuclear medicine departments. Today, tumor SPECT has to compete with tumor PET using F-18-FDG," researchers in Germany reported.
"Other PET radiopharmaceuticals are common only in specialized centers. In comparison to SPECT, PET images with their higher resolution are technically superior. Therefore, PET is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.